Cognetivity Sees Its Cognitive Tool Used In Clinical Study For OCD
While it may have been initially developed for the early detection of Alzheimer’s disease or other cognitive impairments in patients,
Read more
Cognetivity Neurosciences
Cognetivity Enters Paid Pilot Program With Japanese Insurance Giant
Cognetivity Neurosciences (CSE: CGN) appears to be on a roll when it comes to establishing pilot programs in new markets.
Read more
Cognetivity Expands To Asian Market Via Pilot Program In Singapore
Cognetivity Neurosciences (CSE: CGN) continues to expand upon its global reach, this morning announcing its first step into the Asian
Read more
Cognetivity: Tech For Brain Health Screening – The Daily Dive
Joining us again on The Daily Dive is Dr. Thomas Sawyer, COO of Cognetivity Neurosciences (CSE: CGN). Today, Tom sits
Read more
Cognetivity Sees Pilot Program Transition Into Commercial Agreement In UAE
A successful pilot program has lead to a commercial arrangement for Cognetivity Neurosciences (CSE: CGN). The firm this morning revealed
Read more
Cognetivity To Deploy Cognitive Assessment Tool Across Largest Healthcare Network In UAE
Cognetivity Neurosciences (CSE: CGN) continued to take the Middle East by storm this morning. The firm has continued its pattern
Read more
Cognetivity To Deploy Flagship Assessment Tool At Florida-Based Clinic
The rollout of Cognetivity Neurosciences’ (CSE: CGN) flagship product, the CognICA cognitive assessment tool, continues. The firm this morning announced
Read more
Cognetivity To Study Use Of Cognitive Tool To Detect Concussions From Sports
Cognetivity Neuroscience (CSE: CGN) is looking to expand the scope of its cognitive testing platform. The company this morning announced
Read more
Cognetivity Continues Push Into Middle East With Pilot Project
Cognetivity Neurosciences (CSE: CGN) continues to expand its footprint within the Middle East. This morning, the company indicated that it
Read more
Cognetivity Neurosciences Signs Commercial Deal With Dubai Health Authority
Cognetivity Neurosciences (CSE: CGN) continues to expand the deployment of its Integrated Cognitive Assessment, or ICA. The firm this morning
Read more